Biotech Companies Fight Aging at the Cellular Level

Exclusively licensed from the Geron Corp. (Menlo Park, CA, USA), a new product, TA-65, is the world's first telomerase activator.

Telomerase Activation Sciences, Inc. (TA Sciences; New York, NY, USA) announced its license with Geron to develop and market non-therapeutic products using Geron's small molecule telomerase activators. TA Sciences has recently opened the TA Sciences Center in New York City, where customers can purchase TA Sciences' first product, a nutraceutical containing the telomerase-activating agent TA-65.

"TA Sciences welcomes our first customers and the launch of the world's first telemetries-activator product,” said Noel Thomas Patton, founder of TA Sciences. "A natural consequence of aging is the shortening of telomeres [caps of DNA located at the ends of all chromosomes], which ultimately results in loss of cell function. TA-65 offers the potential of reducing or reversing telomere shortening and battles tissue and organ degeneration by rejuvenating aging cells.”

TA-65 is the result of vigorous scientific research that began at Geron in 1992. The response from the scientific community to the news of TA Sciences' launch has been very enthusiastic. "Telomerase Activation is the single most promising approach to reversing the effects of aging,” said Michael Fossel, M.D., Ph.D., clinical professor of medicine at Michigan State University (East Lansing, MI, USA), and specialist on aging and age- related clinical disease.

Moreover, Dr. William H. Andrews, founder of Sierra Sciences, LLC (Reno, NV, USA), and one of the principal discoverers of the telomerase genes, commented, "Cleopatra, Ponce de Leon, and untold others throughout the ages have searched for the secrets of youth. That search has been futile, until now: Telomerase Activation is the first and only scientifically sound way to approach anti-aging. TA-65 is the first product in history that has been proven to slow or reverse cellular aging.”

On April 30, 2007, TA Sciences plans to publish the results of the pivotal 2005 Anti-Aging trial, which is the first ever human-clinical trial of a telomerase activator. This trial shows statistical verification of the anti-aging benefits of telomerase activation.


Related Links:
Geron
Telomerase Activation Sciences